InMode

INMD

Market cap $901M

InMode Ltd. ( INMD ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Moshe Mizrahy - Co-Founder, CEO & Director Yair Malca - Chief Financial Officer Conference Call Participants Miri Segal-Scharia - MS-IR LLC Danielle Antalffy - UBS Investment Bank, Research Division Matthew Miksic - Barclays Bank PLC, Research Division Presentation Operator Good day, and welcome to InMode's Third Quarter 2025 Earnings Results Conference Call.

YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2025.

IRVINE, Calif. , Nov. 3, 2025 /PRNewswire/ -- InMode Ltd.

YOKNEAM, Israel , Oct. 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor conferences in November: UBS Global Healthcare Conference Presenter: Yair Malca, Chief Financial Officer Format: In-person one-on-one meetings Location: Palm Beach Gardens, FL When: Monday, November 10 Jefferies Global Healthcare Conference Presenter: Moshe Mizrahy, Chief Executive Officer Format: In-person fireside chat moderated by Matt Taylor, Senior Equity Analyst, and one-on-one meetings Location: London, U.K. When: Tuesday, November 18, Fireside Chat at 4:00 pm GMT A live webcast of the presentation can be accessed here.

InMode presents an appealing buy opportunity, trading near 52-week lows with strong fundamentals, innovative technology, and global expansion. INMD's minimally invasive platforms drive revenue growth, with international markets and new product launches supporting diversification and future potential. Despite regulatory, tariff, and demand risks, INMD maintains robust margins, a strong cash position, and disciplined cost control, ensuring operational resilience.

Conference call to be held on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd.

Believes the Board Should Approve and Execute a 10% Buyback in Q4 2025 and Another 10% Buyback in Q1 2026 Maintains Board Has Legal and Fiduciary Duty to Act in Best Interests of Shareholders  MIAMI , Sept. 9, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a significant stockholder of InMode Ltd.

YOKNEAM, Israel , Sept. 2, 2025 /PRNewswire/ --  InMode Ltd.

YOKNEAM, Israel , Aug. 5, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor conferences in August: 10th Annual Needham Virtual MedTech & Diagnostics Conference Presenters: Moshe Mizrahy, Chief Executive Officer Format: Virtual one-on-one meetings When: Monday, Aug. 11   Canaccord 45th Annual Global Growth Conference Presenters: Yair Malca, Chief Financial Officer Format: In-person fireside chat moderated by Caitlin Cronin, Director of MedTech Equity Research, and meetings When: Tuesday, Aug. 12 at 2:30 pm ET A live webcast of the presentation can be accessed here.

InMode Ltd. (NASDAQ:INMD ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Moshe Mizrahy - Co-Founder, CEO & Director Yair Malca - Chief Financial Officer Conference Call Participants Caitlin Cronin - Canaccord Genuity Corp., Research Division Danielle Joy Antalffy - UBS Investment Bank, Research Division Jeffrey D.